c-Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin-based therapy. (Q40076507)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | c-Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin-based therapy. |
scientific article |
Statements
c-Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin-based therapy (English)
Clara I Aceves Luquero
Carmen RamÃrez-Castillejo
Juan L Callejas-Valera
Angel Arriaga
Antonio Fernandez Aranburo
J Silvio Gutkind
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference